Survival statistics for childhood Ewing sarcoma

Last medical review:

Survival statistics for childhood Ewing sarcoma are general estimates and must be interpreted very carefully. These statistics are based on the experience of groups of children and can’t be used to predict a particular childʼs chances of survival.

There are many different ways to measure and report cancer survival statistics. Your child’s doctor can explain the statistics for Ewing sarcoma and what they mean for your child.

Overall survival

Overall survival is also called observed survival. Itʼs the percentage of people with a particular cancer who are alive at a certain point in time after their diagnosis. Doctors often use overall survival when they talk about a prognosis.

In Canada, a 5-year overall survival is not reported for childhood Ewing sarcoma. But it is included within the group “malignant bone tumours,” which includes other types of childhood bone cancer.

The 5-year overall survival for “malignant bone tumours” in children 0 to 14 years of age is 72%. This means that, on average, 72% of children diagnosed with malignant bone tumours are expected to live at least 5 years after their diagnosis.

Survival by stage

Survival varies with each stage of childhood Ewing sarcoma. Generally, the earlier Ewing sarcoma is diagnosed and treated, the better the outcome.

There are no specific Canadian statistics available for the different stages of Ewing sarcoma in children. The following information comes from a variety of sources. It may include statistics from other countries that are likely to have similar outcomes as those in Canada.

Table 1. Childhood Ewing sarcoma cancer survival

Stage

5-year overall survival

Localized (cancer has not spread to other parts of the body)

84%

Metastatic (cancer has spread to other parts of the body)

50%

Questions about survival

Talk to the doctor about prognosis. Prognosis depends on many factors, including:

  • the type of cancer
  • the stage
  • certain characteristics of the cancer
  • the treatments chosen
  • how the cancer responds to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.

Expert review and references

  • Kriti Kumar, MD, MHSc FRCPC
  • American Cancer Society. Ewing Sarcoma. 2026: https://www.cancer.org/.
  • St. Jude Children's Research Hospital. Ewing Sarcoma. 2023: https://www.stjude.org/.
  • Lessnick SL, Grohar PJ, DuBois SG, Hogendoorn PCW, Davidson D, Laack NN, Dirksen U. Ewing sarcoma. Pizzo PA, Poplack DG, eds.. Principles and Practice of Pediatric Oncology. 8th ed. Philadelphia, PA: Wolters Kluwer; 2021: 27:3286—3381.
  • Wells, ME, Eckhoff MD, Davis W, Singh V, et al. Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States. American Academy of Orthopaedic Surgeons (AAOS). 2024: 8(10)e24.00281.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society